Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy.
Cells. 2023 Jul 27;12(15):1944. doi: 10.3390/cells12151944.
Mycosis fungoides (MF) is the most common cutaneous lymphoma characterized by an indolent course. Prognosis is stage-based but this approach does not reflect the different outcomes within stages. Considering that tumor microenvironment is known to be involved in MF pathogenesis and progression, we decided to investigate 99 MF cases by using the PanCancer Immune Profiling Panel. We identified and validated a signature of 9 genes able to predict MF survival and distinguish a high-risk group with a worse outcome from a low-risk group of cases with a better outcome. At the molecular level, low-risk vs. high-risk cases reported a global upregulation of immune genes, enriched in cytokines, and a higher density of dendritic cells and mast cells, possibly associated with a more favorable clinical course.
蕈样肉芽肿(MF)是最常见的皮肤淋巴瘤,其特征为惰性病程。预后是基于分期的,但这种方法并不能反映各分期内的不同结局。鉴于已知肿瘤微环境参与 MF 的发病机制和进展,我们决定使用 PanCancer Immune Profiling Panel 对 99 例 MF 病例进行研究。我们鉴定并验证了一个由 9 个基因组成的特征签名,该特征能够预测 MF 的生存,并将预后较差的高危组与预后较好的低危组病例区分开来。在分子水平上,低危组与高危组病例报告了免疫基因的整体上调,富含细胞因子,树突状细胞和肥大细胞密度更高,可能与更有利的临床病程相关。